Request Sample Report

View Synopsis & Table of Content
{reportSlug=global-postmenopausal-vaginal-atrophy-treatment-market, reportId=75039, mktKeyword=Postmenopausal Vaginal Atrophy Treatment, cagr=0.00, publishDate=Jan 2024, priceOption2=6800, reportTitle=Postmenopausal Vaginal Atrophy Treatment Comprehensive Study by Type (Prasterone (Intrarosa)), Application (Vaginal estrogen cream (Estrace, Premarin). You insert this cream directly into your vagina with an applicator, usually at bedtime. ..., Vaginal estrogen suppositories (Imvexxy)., Vaginal estrogen ring (Estring, Femring, Vaginal estrogen tablet (Vagifem).), Drug Form (Vaginal gel, Creams, Tablet, Others), Drug (Estrogen based drugs (Premarin, Vagifem, Estrace, Estring and Femring), Non-estrogen based drugs (BZA/CE, Osphena, and Vaginorm), Others), Route of Administration (Oral, Intravaginal, Others), End User (Hospitals, Specialty Clinics, Others) Players and Region - Global Market Outlook to 2029, baseYr=2023, totalTableFig=175, priceOption1=3650, forecastYr=2029, noOfPages=232, reportKey=74642, breadcrum=Global Postmenopausal Vaginal Atrophy Treatment}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Jan 2024 232 Pages 65 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales
AMA Research - Asia Pacific Client Engagement Partner

Filza Sayed

APAC Client Engagement Partner